The University of Chicago Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Sprague, Stuart
Item TypeName
Concept Hyperphosphatemia
Academic Article Lanthanum carbonate reduces phosphorus burden in patients with CKD stages 3 and 4: a randomized trial.
Academic Article KDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD).
Academic Article Higher strength lanthanum carbonate provides serum phosphorus control with a low tablet burden and is preferred by patients and physicians: a multicenter study.
Academic Article A comparative review of the efficacy and safety of established phosphate binders: calcium, sevelamer, and lanthanum carbonate.
Academic Article A phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patients.
Academic Article Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients.
Academic Article Pharmacodynamic Effects of Sucroferric Oxyhydroxide and Sevelamer Carbonate on Vitamin D Receptor Agonist Bioactivity in Dialysis Patients.
Academic Article Iron-related parameters in dialysis patients treated with sucroferric oxyhydroxide.
Academic Article One-year efficacy and safety of the iron-based phosphate binder sucroferric oxyhydroxide in patients on peritoneal dialysis.
Academic Article Real-world effectiveness of sucroferric oxyhydroxide in patients on chronic hemodialysis: A retrospective analysis of pharmacy data?.
Academic Article Sucroferric oxyhydroxide for the treatment of hyperphosphatemia.
Academic Article Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease-mineral bone disorder parameters in dialysis patients.
Academic Article Should phosphate management be limited to the KDIGO/ KDOQI guidelines?
Academic Article Characteristics of Patients Who Achieve Serum Phosphorus Control on Sucroferric Oxyhydroxide or Sevelamer Carbonate: A post hoc Analysis of a Phase 3 Study.
Academic Article A safety evaluation of sucroferric oxyhydroxide for the treatment of hyperphosphatemia.
Academic Article Small Intestinal Phosphate Absorption: Novel Therapeutic Implications.
Academic Article Sucroferric oxyhydroxide for hyperphosphatemia: a review of real-world evidence.
Academic Article High Phosphate-Binding Capacity of Oxylanthanum Carbonate with a Low Medication Volume: Comparison with Commercially Available Phosphate Binders.
Academic Article Serum Phosphorus Management with Sucroferric Oxyhydroxide as a First-Line Phosphate Binder within the First Year of Hemodialysis.
Academic Article Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study.
Search Criteria
  • Hyperphosphatemia